Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2024-10-03
DOI
https://doi.org/10.3324/haematol.2024.285380
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile

Myo Htut, Paul Gerard Guy Richardson, Claudia Prada, Emma C. Scott et al.
Haematologica
Multiple Myeloma Research and Treatments
article

Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile

Myo Htut, Paul Gerard Guy Richardson, Claudia Prada, Emma C. Scott, Ira Gupta
article en

Abstract

No abstract available for this paper.
HaematologicaVol. 110(2)
Oregon Health & Science University (US), City of Hope (US), Dana-Farber Cancer Institute (US), Dana-Farber/Harvard Cancer Center (US)
Menarini Group
Good health and well-being
Openalex Percentile: Top 72%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile — Myo Htut, Paul Gerard Guy Richardson, et al. · Haematologica (2024) | TGRS Research Map | TGRS